Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Gastric Modulator (TANTALUS® System) Versus Insulin Treatment in Obese Type 2 Diabetic Patients - a Randomized Control Trial

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2009 by Chinese University of Hong Kong.
Recruitment status was  Not yet recruiting
Sponsor:
Collaborator:
Metacure
Information provided by:
Chinese University of Hong Kong
ClinicalTrials.gov Identifier:
NCT00975533
First received: September 10, 2009
Last updated: NA
Last verified: September 2009
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: October 2011
  Estimated Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)